Search Results for: Lumenis

Lumenis exits for $1.2 billion

Israel’s medical-device pioneer Lumenis (reported here previously) is being acquired by Baring Private Equity Asia for approximately $1.2 billion.  Subject to the customary regulatory approval process, it will be one of the 15 biggest acquisitions in Israeli history. https://www.israel21c.org/israeli-medical-device-firm-lumenis-to-be-sold-for-1-2b/?ct=t(Newsletter_2019-11)

Posted in Economy & Business | Leave a comment

Moses 2.0 launched

Israel-headquartered Lumenis (reported here previously) has launched a superior version 2.0 of its Moses platform for minimal and non-invasive laser removal of urinary (bladder) stones and other stones. https://lumenis.com/medical/holmium-products/lumenis-moses-pulse-120h/ https://lumenis.com/medical/specialties/urology/resource-hub/lumenis-launches-next-generation-moses-2-0-holmium-laser-technology/

Posted in Israel's Medical Achievements | Leave a comment

Moses wins excellence award

I reported previously (23rd Oct) on the Moses laser from Israel’s Lumenis that urologists were using to smash bladder stones. Its technology was the Silver Winner in the Operating Room Medical Device category of the 21st Annual Medical Design Excellence … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

“Moses” blasts bladder stones

Conventional treatment of bladder stones uses a laser that causes the stone to be repelled, extending the time taken to destroy it. Israeli biotech Lumenis’ laser technology (named “Moses”) keeps the stone in place, saving time, anesthesia and money.  Nice … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Lebanon uses Israeli cosmetic products

Campaigners to boycott Israel have exposed the “scandal” on the Arab media site Alakhbar. Israeli products include those from Syneron, Lumenis, Alma and Invasix. The EoZ site highlights that these products also remove disfigurations on children, and Lebanon uses many … Continue reading

Posted in Economy & Business | Leave a comment